Literature DB >> 22421538

Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection.

Adam C Soloff1, Heather K Weirback, Ted M Ross, Simon M Barratt-Boyes.   

Abstract

Plasmacytoid dendritic cells (pDCs) have been implicated both in the control and pathogenesis of influenza virus infection. We demonstrate that pDC depletion has marked effects on the response of mononuclear phagocytes, including conventional DCs (cDCs) and macrophages, to lethal influenza virus infection. Infection of mice lacking pDCs through antibody-mediated depletion resulted in substantially increased accumulation of mononuclear phagocytes and their progenitors in lungs compared to non-treated controls. pDC ablation resulted in a 5- to 35-fold enhancement of intracellular TNF-α and IL-6 production from inflammatory cDCs and exudate macrophages. Purified pulmonary cDCs and macrophages cultured from pDC-depleted mice produced significantly elevated levels of pro-inflammatory cytokines and chemokines compared to pDC-intact counterparts. Elimination of pDCs resulted in decreased lung IFN-α production and an immediate and transient reduction in lung virus burden but did not impact disease outcome. These data reveal a suppressive effect of pDCs on the inflammatory response to influenza virus infection in the lung.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421538      PMCID: PMC3368063          DOI: 10.1016/j.cimid.2012.01.012

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  62 in total

1.  Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights.

Authors:  Karim Vermaelen; Romain Pauwels
Journal:  Cytometry A       Date:  2004-10       Impact factor: 4.355

2.  In vivo analysis of dendritic cell development and homeostasis.

Authors:  Kang Liu; Gabriel D Victora; Tanja A Schwickert; Pierre Guermonprez; Matthew M Meredith; Kaihui Yao; Fei-Fan Chu; Gwendalyn J Randolph; Alexander Y Rudensky; Michel Nussenzweig
Journal:  Science       Date:  2009-03-12       Impact factor: 47.728

Review 3.  Innate immune control and regulation of influenza virus infections.

Authors:  Jodi McGill; Jonathan W Heusel; Kevin L Legge
Journal:  J Leukoc Biol       Date:  2009-07-30       Impact factor: 4.962

4.  Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.

Authors:  Adam C Soloff; Xiangdong Liu; Wentao Gao; Richard D Day; Andrea Gambotto; Simon M Barratt-Boyes
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

5.  Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection.

Authors:  Tobias M Hohl; Amariliz Rivera; Lauren Lipuma; Alena Gallegos; Chao Shi; Mathias Mack; Eric G Pamer
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

Review 6.  Plasmacytoid dendritic cells in immunity.

Authors:  Marco Colonna; Giorgio Trinchieri; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2004-12       Impact factor: 25.606

7.  Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain.

Authors:  Masaya Fukushi; Tateki Ito; Teruaki Oka; Toshio Kitazawa; Tohru Miyoshi-Akiyama; Teruo Kirikae; Makoto Yamashita; Koichiro Kudo
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

8.  Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection.

Authors:  Heung Kyu Lee; Melodie Zamora; Melissa M Linehan; Norifumi Iijima; David Gonzalez; Ann Haberman; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

9.  Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Authors:  Hiroyuki Yoneyama; Kenjiro Matsuno; Etsuko Toda; Tetsu Nishiwaki; Naoki Matsuo; Akiko Nakano; Shosaku Narumi; Bao Lu; Craig Gerard; Sho Ishikawa; Kouji Matsushima
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  6 in total

1.  Resident plasmacytoid dendritic cells patrol vessels in the naïve limbus and conjunctiva.

Authors:  Arsia Jamali; Deshea L Harris; Tomas Blanco; Maria J Lopez; Pedram Hamrah
Journal:  Ocul Surf       Date:  2020-02-25       Impact factor: 5.033

2.  Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection.

Authors:  Moon Cheol Kang; Han Wook Park; Dong-Hoon Choi; Young Woo Choi; Yunji Park; Young Chul Sung; Seung-Woo Lee
Journal:  Immune Netw       Date:  2017-10-24       Impact factor: 6.303

Review 3.  The Role of Innate Leukocytes during Influenza Virus Infection.

Authors:  Prem P Lamichhane; Amali E Samarasinghe
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

Review 4.  Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus.

Authors:  Sindhu Vangeti; Meng Yu; Anna Smed-Sörensen
Journal:  Front Immunol       Date:  2018-07-03       Impact factor: 7.561

Review 5.  Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae.

Authors:  Kim S LeMessurier; Meenakshi Tiwary; Nicholas P Morin; Amali E Samarasinghe
Journal:  Front Immunol       Date:  2020-02-04       Impact factor: 7.561

Review 6.  Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity.

Authors:  Christopher M Harpur; Mélanie A Le Page; Michelle D Tate
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.